Literature DB >> 14886751

Modern use of urinary antiseptics.

F HINMAN.   

Abstract

It is not necessary to resort to complete study in most cases of urinary tract infection. However, if the lesion is chronic or recurrent, associated with mixed organisms, complicated by lower tract involvement, accompanied by low total renal function, with or without abnormalities in a kidney-ureter-bladder x-ray film or in an intravenous urogram, then complete retrograde study should be carried out.A Gram stain will substitute for culture in most simple urinary tract infections and a trial of the agent of choice will act as a test of bacterial sensitivity. If the infection persists, however, more adequate bacteriologic studies are required. FOR GOOD CHEMOTHERAPEUTIC PRACTICE, IT IS IMPORTANT TO: (1) Withhold the drug until it has been determined that obstruction, stone or other such lesion is not present; (2) watch for side effects and toxicity; and (3) give the best drug in large enough dosage for an adequate period of time.

Entities:  

Keywords:  ANTIBIOTICS/therapeutic use; URINARY TRACT/diseases

Mesh:

Substances:

Year:  1952        PMID: 14886751      PMCID: PMC1521195     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  37 in total

1.  The Combined Action of Penicillin with Streptomycin or Chloromycetin on Enterococci in Vitro.

Authors:  E Jawetz; J B Gunnison; V R Coleman
Journal:  Science       Date:  1950-03-10       Impact factor: 47.728

2.  Polymyxin B and polymyxin E; clinical and laboratory studies.

Authors:  B M KAGAN; D KREVSKY; A MILZER; M LOCKE
Journal:  J Lab Clin Med       Date:  1951-03

3.  Studies on antibiotic synergism and antagonism; the interference of chloramphenicol with the action of penicillin.

Authors:  E JAWETZ; J B GUNNISON; R S SPECK; V R COLEMAN
Journal:  AMA Arch Intern Med       Date:  1951-03

4.  The use of antibiotics in urology.

Authors:  F HINMAN
Journal:  Ann West Med Surg       Date:  1950-12

5.  Indications for aureomycin and chloromycetin in urinary infections.

Authors:  R D HERROLD; A V BOAND
Journal:  J Urol       Date:  1950-10       Impact factor: 7.450

6.  Blood levels and urinary excretion of aureomycin after intravenous and intramuscular administration.

Authors:  T M GOCKE; E B WELLS; H S COLLINS; M FINLAND
Journal:  J Lab Clin Med       Date:  1950-07

7.  A new sulfonamide, gantrisin; studies on solubility, absorption and excretion.

Authors:  F A SVEC; P S RHOADS; J H ROHR
Journal:  Arch Intern Med (Chic)       Date:  1950-01

8.  On the Mechanism of Action of Aureomycin.

Authors:  W F Loomis
Journal:  Science       Date:  1950-04-28       Impact factor: 47.728

9.  Neomycin, a New Antibiotic Active against Streptomycin-Resistant Bacteria, including Tuberculosis Organisms.

Authors:  S A Waksman; H A Lechevalier
Journal:  Science       Date:  1949-03-25       Impact factor: 47.728

10.  The clinical use of NU-445 (gantrisin) in the treatment of urinary tract infections; a report of 100 cases.

Authors:  B L STEWART; J J LASH
Journal:  J Urol       Date:  1950-12       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.